Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
The global Peripheral Intervention Drug-Eluting Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Peripheral Intervention Drug-Eluting Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Peripheral Intervention Drug-Eluting Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Peripheral Intervention Drug-Eluting Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peripheral Intervention Drug-Eluting Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Peripheral Intervention Drug-Eluting Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Peripheral Intervention Drug-Eluting Devices sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Segment by Type
Drug-Eluting Balloons
Drug-Eluting Stents
Segment by Application
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Peripheral Intervention Drug-Eluting Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Peripheral Intervention Drug-Eluting Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Intervention Drug-Eluting Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Market by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Market by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts 2019-2030
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2024)
2.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2025-2030)
2.2.4 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2019-2030)
2.3 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts 2019-2030
2.4 Global Peripheral Intervention Drug-Eluting Devices Sales by Region
2.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2024)
2.4.3 Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2025-2030)
2.4.4 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers
3.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturers (2019-2024)
3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peripheral Intervention Drug-Eluting Devices in 2023
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2023
3.3 Global Key Players of Peripheral Intervention Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Peripheral Intervention Drug-Eluting Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Offered and Application
3.8 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Type (2019-2024)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2019-2030)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Type (2019-2024)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2019-2030)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type
4.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2019-2024)
4.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Historical Sales by Application (2019-2024)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2019-2030)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Historical Revenue by Application (2019-2024)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2019-2030)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application
5.3.1 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2019-2024)
5.3.2 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Peripheral Intervention Drug-Eluting Devices Market Size by Type
6.1.1 US & Canada Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
6.1.2 US & Canada Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
6.2 US & Canada Peripheral Intervention Drug-Eluting Devices Market Size by Application
6.2.1 US & Canada Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
6.2.2 US & Canada Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
6.3 US & Canada Peripheral Intervention Drug-Eluting Devices Market Size by Country
6.3.1 US & Canada Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
6.3.3 US & Canada Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Type
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Application
7.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
7.2.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
7.3 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country
7.3.1 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
7.3.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Peripheral Intervention Drug-Eluting Devices Market Size
8.1.1 China Peripheral Intervention Drug-Eluting Devices Sales (2019-2030)
8.1.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2019-2030)
8.2 China Peripheral Intervention Drug-Eluting Devices Market Size by Application
8.2.1 China Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
8.2.2 China Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Peripheral Intervention Drug-Eluting Devices Market Size by Type
9.1.1 Asia Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
9.1.2 Asia Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
9.2 Asia Peripheral Intervention Drug-Eluting Devices Market Size by Application
9.2.1 Asia Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
9.2.2 Asia Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
9.3 Asia Peripheral Intervention Drug-Eluting Devices Sales by Region
9.3.1 Asia Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Peripheral Intervention Drug-Eluting Devices Revenue by Region (2019-2030)
9.3.3 Asia Peripheral Intervention Drug-Eluting Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic plc
11.1.1 Medtronic plc Company Information
11.1.2 Medtronic plc Overview
11.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic plc Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Information
11.2.2 Boston Scientific Corporation Overview
11.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boston Scientific Corporation Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Laboratories Recent Developments
11.4 Cardinal Health
11.4.1 Cardinal Health Company Information
11.4.2 Cardinal Health Overview
11.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cardinal Health Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Information
11.5.2 B. Braun Melsungen AG Overview
11.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 Biosensors International Group Ltd.
11.6.1 Biosensors International Group Ltd. Company Information
11.6.2 Biosensors International Group Ltd. Overview
11.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosensors International Group Ltd. Recent Developments
11.7 C.R. Bard, Inc.
11.7.1 C.R. Bard, Inc. Company Information
11.7.2 C.R. Bard, Inc. Overview
11.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 C.R. Bard, Inc. Recent Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Overview
11.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
11.9 The Lubrizol Corporation
11.9.1 The Lubrizol Corporation Company Information
11.9.2 The Lubrizol Corporation Overview
11.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 The Lubrizol Corporation Recent Developments
11.10 Terumo Corporation
11.10.1 Terumo Corporation Company Information
11.10.2 Terumo Corporation Overview
11.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Terumo Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
12.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
12.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
12.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
12.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
12.5 Peripheral Intervention Drug-Eluting Devices Customers
13 Market Dynamics
13.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
13.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
13.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
13.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
14 Key Findings in The Global Peripheral Intervention Drug-Eluting Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
听
听
*If Applicable.
